Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The collaboration between the chipmaker and Abridge, a developer of generative AI for healthcare, will involve data-sharing to improve Nvidia’s general-purpose models, which in turn will be used to make Abridge’s clinical offerings more efficient.
The Kentucky-based insurance giant had owned a 40% stake in the hospice company, stemming from its 2021 acquisition of Kindred Healthcare. Humana said a “consortium of investors" is making the buy, but few details were revealed.
The buyout, announced last summer, drew the attention of federal regulators at the Federal Trade Commission, concerned that competition for ambulatory surgery services would be stifled by the merger. To appease the agency, Ascension has agreed to divest from some centers previously owned by Amsurg.
When Mayo Clinic and Microsoft announced last week that they’re partnering to develop a frontier AI model for healthcare, observers could see where Mayo’s expertise in advanced digital medicine would interest Microsoft. The Big Tech behemoth has not been coy about its healthcare ambitions.
Patient Square Capital will be taking the company private when the all-cash deal closes in the first quarter of 2026, pending approval from Premier’s shareholders.
In May, a jury found the CVS subsidiary liable for filing 3.3 million fraudulent insurance claims between 2010 and 2018. The $949 million judgment was imposed in July.
Both companies are working on ChatGPT-like platforms designed exclusively for medical professionals. OpenEvidence accuses Doximity of attempting to steal its proprietary code, while the latter fires back with a defamation claim.
The data comes from a new report by cybersecurity firm Netwrix, which found that healthcare continues to outpace other sectors in both number of breaches and associated financial losses.
The Wall Street Journal said that President Donald Trump has yet to meet with company representatives. However, UnitedHealth CEO Stephen Hemsley reportedly met with members of the administration in Washington.
The U.S. Food and Drug Administration announced a recall of Mo-Vis BVBA joysticks after a faulty firmware version was linked to the malfunction. Users will need to have their devices upgraded.